Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States
Document Type
Article
Department
Cardiology; Office of the Provost
Abstract
Aim: We assessed self-reported efficacy in cardiovascular prevention practice among internal medicine, family medicine, endocrinology and cardiology clinicians.
Patients & methods: We emailed a 21-item questionnaire to 956 physicians, nurse practitioners, physician assistants and pharmacists.
Results: 264 clinicians responded (median age: 39 years, 55% women, 47.9% specialists). Most expressed high self-efficacy in lifestyle counselling, prescribing statins, metformin, and aspirin in primary prevention, but low self-efficacy in managing specialized conditions like elevated lipoprotein(a). Compared with specialists, PCPs expressed lower self-efficacy in managing advanced lipid disorders and higher self-efficacy in prescribing sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide-1 receptor agonists.
Conclusion: Self-efficacy in cardiovascular prevention varied across specialties. Future research should explore relevant provider, clinic and system level factors to optimize cardiovascular prevention.
Publication (Name of Journal)
Future Cardiology
DOI
10.2217/fca-2023-0040
Recommended Citation
Caldarera, T.,
Ponir, C.,
Seals, A.,
Penmetsa, M.,
Ip, E.,
German, C. A.,
Virani, S. S.,
Saha, A.,
Bosworth, H. B.,
Moore, J. B.
(2023). Clinicians' self-reported efficacy in cardiovascular prevention practice in the southeastern United States. Future Cardiology, 19(12), 593-604.
Available at:
https://ecommons.aku.edu/provost_office/517